PremiumBlurbsAnalysts Offer Insights on Healthcare Companies: Climb Bio (CLYM) and Longeveron (LGVN)15h agoCLYMLGVN
PremiumAI Analyst RatingsAI Models Upgrade AXTI on Turnaround Momentum, But Valuation Stays a Concern18h agoAXTI
PremiumRatingsCLYM116’s Differentiated APRIL ‘Sweeper’ Design Sets Up Phase I Data as Key Catalyst for IgA Nephropathy Outlook18h agoCLYM
CLYM116’s Differentiated APRIL ‘Sweeper’ Design Sets Up Phase I Data as Key Catalyst for IgA Nephropathy Outlook